358 related articles for article (PubMed ID: 8506338)
1. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages.
Kovacsovics-Bankowski M; Clark K; Benacerraf B; Rock KL
Proc Natl Acad Sci U S A; 1993 Jun; 90(11):4942-6. PubMed ID: 8506338
[TBL] [Abstract][Full Text] [Related]
2. Presentation of exogenous antigen with class I major histocompatibility complex molecules.
Rock KL; Gamble S; Rothstein L
Science; 1990 Aug; 249(4971):918-21. PubMed ID: 2392683
[TBL] [Abstract][Full Text] [Related]
3. Delivery of exogenous antigen into the major histocompatibility complex class I and class II pathways by electroporation.
Li Y; Ke Y; Gottlieb PD; Kapp JA
J Leukoc Biol; 1994 Nov; 56(5):616-24. PubMed ID: 7525819
[TBL] [Abstract][Full Text] [Related]
4. Inhibition of class I and class II MHC-restricted antigen presentation by cytotoxic T lymphocytes specific for an exogenous antigen.
Rock KL; Rothstein L; Fleischacker C; Gamble S
J Immunol; 1992 May; 148(10):3028-33. PubMed ID: 1578128
[TBL] [Abstract][Full Text] [Related]
5. Bacterial antigen delivery systems: phagocytic processing of bacterial antigens for MHC-I and MHC-II presentation to T cells.
Svensson M; Pfeifer J; Stockinger B; Wick MJ
Behring Inst Mitt; 1997 Feb; (98):197-211. PubMed ID: 9382741
[TBL] [Abstract][Full Text] [Related]
6. Major histocompatibility complex class I presentation of peptides derived from soluble exogenous antigen by a subset of cells engaged in phagocytosis.
Reis e Sousa C; Germain RN
J Exp Med; 1995 Sep; 182(3):841-51. PubMed ID: 7650490
[TBL] [Abstract][Full Text] [Related]
7. MHC class I-restricted presentation of exogenous antigen by thymic antigen-presenting cells in vitro and in vivo.
Grant EP; Rock KL
J Immunol; 1992 Jan; 148(1):13-8. PubMed ID: 1727862
[TBL] [Abstract][Full Text] [Related]
8. IL-3 enhances both presentation of exogenous particulate antigen in association with class I major histocompatibility antigen and generation of primary tumor-specific cytolytic T lymphocytes.
Yeh KY; McAdam AJ; Pulaski BA; Shastri N; Frelinger JG; Lord EM
J Immunol; 1998 Jun; 160(12):5773-80. PubMed ID: 9637487
[TBL] [Abstract][Full Text] [Related]
9. Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines.
Kovacsovics-Bankowski M; Rock KL
Eur J Immunol; 1994 Oct; 24(10):2421-8. PubMed ID: 7925570
[TBL] [Abstract][Full Text] [Related]
10. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules.
Harding CV; Song R
J Immunol; 1994 Dec; 153(11):4925-33. PubMed ID: 7963555
[TBL] [Abstract][Full Text] [Related]
11. Electroporation and commercial liposomes efficiently deliver soluble protein into the MHC class I presentation pathway. Priming in vitro and in vivo for class I-restricted recognition of soluble antigen.
Chen W; Carbone FR; McCluskey J
J Immunol Methods; 1993 Mar; 160(1):49-57. PubMed ID: 7680698
[TBL] [Abstract][Full Text] [Related]
12. Analysis of the role of MHC class II presentation in the stimulation of cytotoxic T lymphocytes by antigens targeted into the exogenous antigen-MHC class I presentation pathway.
Rock KL; Clark K
J Immunol; 1996 May; 156(10):3721-6. PubMed ID: 8621907
[TBL] [Abstract][Full Text] [Related]
13. Dendritic cell/macrophage precursors capture exogenous antigen for MHC class I presentation by dendritic cells.
Mitchell DA; Nair SK; Gilboa E
Eur J Immunol; 1998 Jun; 28(6):1923-33. PubMed ID: 9645374
[TBL] [Abstract][Full Text] [Related]
14. Class I restricted CTL recognition of a soluble protein delivered by liposomes containing lipophilic polylysines.
Nair S; Zhou X; Huang L; Rouse BT
J Immunol Methods; 1992 Aug; 152(2):237-43. PubMed ID: 1386866
[TBL] [Abstract][Full Text] [Related]
15. Accessory cell requirements for saponin adjuvant-induced class I MHC antigen-restricted cytotoxic T-lymphocytes.
Wu JY; Gardner BH; Kushner NN; Pozzi LA; Kensil CR; Cloutier PA; Coughlin RT; Newman MJ
Cell Immunol; 1994 Apr; 154(1):393-406. PubMed ID: 7907530
[TBL] [Abstract][Full Text] [Related]
16. Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo.
Carbone FR; Bevan MJ
J Exp Med; 1990 Feb; 171(2):377-87. PubMed ID: 2137512
[TBL] [Abstract][Full Text] [Related]
17. The efficiency of antigen delivery from macrophage phagosomes into cytoplasm for MHC class I-restricted antigen presentation.
Oh YK; Harding CV; Swanson JA
Vaccine; 1997 Apr; 15(5):511-8. PubMed ID: 9160518
[TBL] [Abstract][Full Text] [Related]
18. Major histocompatibility class I presentation of soluble antigen facilitated by Mycobacterium tuberculosis infection.
Mazzaccaro RJ; Gedde M; Jensen ER; van Santen HM; Ploegh HL; Rock KL; Bloom BR
Proc Natl Acad Sci U S A; 1996 Oct; 93(21):11786-91. PubMed ID: 8876215
[TBL] [Abstract][Full Text] [Related]
19. Major histocompatibility complex class I presentation of ovalbumin peptide 257-264 from exogenous sources: protein context influences the degree of TAP-independent presentation.
Wick MJ; Pfeifer JD
Eur J Immunol; 1996 Nov; 26(11):2790-9. PubMed ID: 8921970
[TBL] [Abstract][Full Text] [Related]
20. Characterization of antigen-presenting cells that present exogenous antigens in association with class I MHC molecules.
Rock KL; Rothstein L; Gamble S; Fleischacker C
J Immunol; 1993 Jan; 150(2):438-46. PubMed ID: 8419476
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
